Population
Chaired baboons with femoral arteriovenous cannulae (n=4 for renal artery extension segment experiment)
Comparison
Oral administration of dipyridamole… vs Baseline/control conditions
Design
Preclinical
Follow-up
months
Authors
Loading...
Suggests limited aspirin role in device thrombosis; extends primate model but leaves human translation open.
A primate model of arterial thromboembolism demonstrates that dipyridamole and sulfinpyrazone, but not aspirin, effectively interrupt platelet consumption on thrombogenic surfaces.
Harker et al. (1979) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: